TANG CAPITAL MANAGEMENT LLC
Filing Date
Global Rank
#1,044
/ 7,976
▲ 168
Top Industry
Biotechnology
80.8%
3Y Alpha vs SPY
-0.6%
Period ended 9 months ago
Filed Nov 14, 2025 · 7mo
23 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+73.8%
SPY
+76.3%
Annualised alpha
-0.6%
Max drawdown
−31.5%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
183 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
6.0%
−0.3 pts
Top 5
24.4%
+0.7 pts
Top 10
38.9%
+0.4 pts
HHI
226
Diversified+5
Portfolio Trend
23 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 94.7% | $2,317,781,279 |
| Consumer Cyclical | 2.2% | $53,413,768 |
| Technology | 1.3% | $30,798,612 |
| Communication Services | 0.9% | $22,981,962 |
| Financial Services | 0.3% | $7,669,713 |
| Consumer Defensive | 0.2% | $5,435,321 |
| Real Estate | 0.2% | $4,349,600 |
| Industrials | 0.1% | $3,450,828 |
| Energy | 0.1% | $1,895,841 |
| Basic Materials | 0.0% | $484,071 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | +3,315,755 | 16,811,963 | $58,841,870 | |
| HRTX | Heron Therapeutics, Inc. /De/ | +1,314,541 | 3,450,000 | $4,347,000 | |
| AUPH | Aurinia Pharmaceuticals Inc. | +1,300,000 | 11,329,500 | $125,190,975 | |
| CMPS | COMPASS Pathways plc | +900,000 | 2,200,000 | $12,606,000 | |
| CBIO | Crescent Biopharma, Inc. | +629,672 | 679,824 | $8,083,107 | |
| BHC | Bausch Health Companies Inc. | +563,173 | 1,300,000 | $8,385,000 | |
| VSTM | Verastem, Inc. | +519,810 | 789,810 | $6,974,022 | |
| JANX | Janux Therapeutics, Inc. | +500,000 | 700,000 | $17,108,000 | |
| NKE | NIKE, Inc. | +500,000 | 519,399 | $36,217,692 | |
| VKTX | Viking Therapeutics, Inc. | +500,000 | 870,000 | $22,863,600 | |
| EOLS | Evolus, Inc. | +490,900 | 5,488,299 | $33,698,155 | |
| IONS | Ionis Pharmaceuticals Inc | +400,000 | 550,000 | $35,981,000 | |
| PTCT | Ptc Therapeutics, Inc. | +400,000 | 1,500,000 | $92,055,000 | |
| FENC | Fennec Pharmaceuticals Inc. | +314,066 | 334,593 | $3,131,790 | |
| SMMT | Summit Therapeutics Inc. | +300,000 | 550,000 | $11,363,000 | |
| NUVB | Nuvation Bio Inc. | +300,000 | 4,200,000 | $15,540,000 | |
| IMCR | Immunocore Holdings plc | +200,000 | 2,305,608 | $83,762,738 | |
| REPL | Replimune Group, Inc. | +200,000 | 3,400,000 | $14,246,000 | |
| SRPT | Sarepta Therapeutics, Inc. | +179,700 | 600,000 | $11,562,000 | |
| LKFT | Lakefront Biotherapeutics NV | +161,083 | 4,151,194 | $143,797,360 | |
| CNTA | Centessa Pharmaceuticals plc | +150,000 | 200,000 | $4,850,000 | |
| KALV | KalVista Pharmaceuticals, Inc. | +100,000 | 5,041,798 | $61,409,099 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | +70,000 | 80,000 | $31,331,200 | |
| KLRS | Kalaris Therapeutics, Inc. | +57,382 | 418,241 | $2,417,432 | |
| BEAM | Beam Therapeutics Inc. | +50,000 | 255,000 | $6,188,850 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IOVA | Iovance Biotherapeutics, Inc. | −1,256,240 | 543,760 | $1,179,959 | |
| ALMS | Alumis Inc. | −829,788 | 1,167,009 | $4,656,365 | |
| ALT | Altimmune, Inc. | −618,693 | 2,131,307 | $8,035,027 | |
| FLNA | Filana Therapeutics, Inc. | −232,747 | 7,073 | $20,582 | |
| MGX | Metagenomi Therapeutics, Inc. | −171,992 | 28,008 | $66,378 | |
| BLCO | Bausch & Lomb Corp | −105,533 | 444,467 | $6,698,117 | |
| BA | Boeing Co | −102,437 | 3,225 | $696,051 | |
| SNY | Sanofi | −100,000 | 100,000 | $4,720,000 | |
| AVIR | Atea Pharmaceuticals, Inc. | −63,000 | 4,826,200 | $13,995,980 | |
| OKUR | OnKure Therapeutics, Inc. | −52,850 | 116,395 | $320,086 | |
| F | Ford Motor Co | −31,999 | 43,381 | $518,836 | |
| MTD | Mettler Toledo International Inc/ | −17,531 | 1,969 | $2,417,164 | |
| HPE | Hewlett Packard Enterprise Co | −16,439 | 23,563 | $578,707 | |
| HRL | Hormel Foods Corp /De/ | −11,913 | 16,181 | $400,317 | |
| SEE | SEALED AIR CORP/DE | −10,126 | 14,274 | $504,585 | |
| UAL | United Airlines Holdings, Inc. | −3,769 | 6,296 | $607,564 | |
| WHR | Whirlpool Corp /De/ | −3,218 | 4,335 | $340,731 | |
| PAYX | Paychex Inc | −2,506 | 3,542 | $448,983 | |
| CVX | Chevron Corp | −2,216 | 3,023 | $469,441 | |
| CLX | Clorox Co /De/ | −2,102 | 3,052 | $376,311 | |
| GE | General Electric Co | −1,992 | 2,994 | $900,655 | |
| ALL | Allstate Corp | −1,788 | 2,700 | $579,555 | |
| AMZN | Amazon Com Inc | −1,731 | 2,583 | $567,149 | |
| TMUS | T-Mobile US, Inc. | −1,511 | 2,285 | $546,983 | |
| AXP | American Express Co | −1,237 | 1,931 | $641,400 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
12 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CELC | Celcuity Inc. | 1,150,000 | $56,810,000 | |
| PGEN | Precigen, Inc. | 12,400,000 | $40,796,000 | |
| IDYA | IDEAYA Biosciences, Inc. | 400,000 | $10,884,000 | |
| PMVP | PMV Pharmaceuticals, Inc. | 4,785,201 | $6,699,281 | |
| CRSP | CRISPR Therapeutics AG | 100,000 | $6,481,000 | |
| VOR | Vor Biopharma Inc. | 50,000 | $2,436,000 | |
| GOSS | Gossamer Bio, Inc. | 800,000 | $2,104,000 | |
| CGTX | Cognition Therapeutics Inc | 1,200,000 | $1,620,000 | |
| PASG | Passage BIO, Inc. | 75,000 | $602,250 | |
| GHRS | GH Research PLC | 24,030 | $343,629 | |
| LONA | LeonaBio, Inc. | 59,998 | $248,391 | |
| PACB | Pacific Biosciences Of California, Inc. | 25,000 | $32,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
8 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ELAN | Elanco Animal Health Inc | 800,100 | $11,425,428 | |
| NVAX | Novavax Inc | 600,000 | $3,780,000 | |
| ALXO | Alx Oncology Holdings Inc | 3,158,265 | $1,310,679 | |
| ALGS | Aligos Therapeutics, Inc. | 141,131 | $1,017,554 | |
| TPST | Tempest Therapeutics, Inc. | 138,962 | $944,941 | |
| MCRB | Seres Therapeutics, Inc. | 13,921 | $154,662 | |
| ACTU | Actuate Therapeutics, Inc. | 5,243 | $32,034 | |
| GALT | Galectin Therapeutics Inc | 12,913 | $27,246 | |
| No positions match the current search. | ||||
5 positions ·
$5,435,321 total
· Consumer Defensive only
· as of Sep 30, 2025
All sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| WMT |
Walmart Inc.
Consumer Defensive
|
Held | 17,242 | $1,776,960 | 32.69% | |
| KO |
Coca Cola Co
Consumer Defensive
|
Held | 22,712 | $1,506,259 | 27.71% | |
| PG |
PROCTER & GAMBLE Co
Consumer Defensive
|
Held | 8,952 | $1,375,474 | 25.31% | |
| HRL |
Hormel Foods Corp /De/
Consumer Defensive
|
Reduced | 16,181 | $400,317 | 7.37% | |
| CLX |
Clorox Co /De/
Consumer Defensive
|
Reduced | 3,052 | $376,311 | 6.92% |